Immunization of preterm infants

References

• Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75-84; PMID:18177778; http://dx.doi.org/10.1016/S0140-6736(08)60074-4
   PubMed Web of Science ®Google Scholar
• Mamelle N, David S, Vendittelli F, Pinquier D, Claris O, Maria B, Mares P. Perinatal health indicators in 2001 and its evolution since 1994. Results from the Audipog sentinel network. Gynecol Obstet Fertil 2002; 30(Suppl. 1):6-39; PMID:12661112
   PubMedGoogle Scholar
• Gaudelus J, Pinquier D, Romain O, Thiebault G, Vie le Sage F, Dommergues MA, Hau I, Bakhache P, Virey B, Dufour V, et al. Is the new vaccination schedule recommended in France adapted to premature babies?. Arch Pediatr 2014; 21:1062-70; PMID:25153808; http://dx.doi.org/10.1016/j.arcped.2014.06.020
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110:285-91; PMID:12165580; http://dx.doi.org/10.1542/peds.110.2.285
   PubMed Web of Science ®Google Scholar
• Langkamp DL, Davis JP. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J Pediatr 1996; 128:654-9; PMID:8627438; http://dx.doi.org/10.1016/S0022-3476(96)80131-4
   PubMed Web of Science ®Google Scholar
• Marshall H, Clarke M, Rasiah K, Richmond P, Buttery J, Reynolds G, Andrews R, Nissen M, Wood N, McIntyre P. Predictors of Disease Severity in Children Hospitalized for Pertussis during an Epidemic. Pediatr Infect Dis J 2015; 34:339-45.
   Web of Science ®Google Scholar
• CA American Academy of Pediatrics. Immunization of preterm and low birth weight infants. Pediatrics 2003; 112:193-8; PMID:12837889; http://dx.doi.org/10.1542/peds.112.1.193
   PubMed Web of Science ®Google Scholar
• CA Canadian Immunization guide. Part 3: Vaccination of Specific Populations. Immunization of Infants Born Prematurely. Available at http://www.phac-aspc.gc.ca/publicat/cig-gci/p03-05-eng.php
   Google Scholar
• Tozzi AE, Piga S, Corchia C, Di Lallo D, Carnielli V, Chiandotto V, Fertz MC, Miniaci S, Rusconi F, Cuttini M. Timeliness of routine immunization in a population-based Italian cohort of very preterm infants: results of the ACTION follow-up project. Vaccine 2014; 32:793-9; PMID:24397902; http://dx.doi.org/10.1016/j.vaccine.2013.12.044
   PubMed Web of Science ®Google Scholar
• Pfister RE, Aeschbach V, Niksic-Stuber V, Martin BC, Siegrist CA. Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory events. J Pediatr 2004; 145:58-66; PMID:15238908; http://dx.doi.org/10.1016/j.jpeds.2004.04.006
   PubMed Web of Science ®Google Scholar
• Schulzke S, Heininger U, Lucking-Famira M, Fahnenstich H. Apnoea and bradycardia in preterm infants following immunisation with pentavalent or hexavalent vaccines. Eur J Pediatr 2005; 164:432-5; PMID:15843978; http://dx.doi.org/10.1007/s00431-005-1674-3
   PubMed Web of Science ®Google Scholar
• Sanchez PJ, Laptook AR, Fisher L, Sumner J, Risser RC, Perlman JM.. Apnea after immunization of preterm infants. J Pediatr 1997; 130:746-51; PMID:9152284; http://dx.doi.org/10.1016/S0022-3476(97)80017-0
   PubMed Web of Science ®Google Scholar
• Botham SJ, Isaacs D. Incidence of apnoea and bradycardia in preterm infants following triple antigen immunization. J Paediatr Child Health 1994; 30:533-5; PMID:7865269; http://dx.doi.org/10.1111/j.1440-1754.1994.tb00728.x
   PubMed Web of Science ®Google Scholar
• Klein NP, Massolo ML, Greene J, Dekker CL, Black S, Escobar GJ. Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics 2008; 121:463-9; PMID:18310193; http://dx.doi.org/10.1542/peds.2007-1462
   PubMed Web of Science ®Google Scholar
• Gaudelus J, Lefèvre-Akriche S, Roumegoux C, Bolie S, Belasco C, Letamendia-Richard E, Lachassinne E. Immunization of the preterm infant. Arch Pediatr. 2007; 14:S24-30; PMID:17939954; http://dx.doi.org/10.1016/S0929-693X(07)80007-8
   PubMedGoogle Scholar
• Shinefield H, Black S, Ray P, Fireman B, Schwalbe J, Lewis E. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J 2002; 21:182-6; PMID:12005078; http://dx.doi.org/10.1097/00006454-200203000-00003
   PubMed Web of Science ®Google Scholar
• Goveia MG, Rodriguez ZM, Dallas MJ, Itzler RF, Boslego JW, Heaton PM, DiNubile MJ. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. PIDJ 2007; 26:1099-1104; PMID:18043445
   PubMed Web of Science ®Google Scholar
• Newman RD, Grupp-Phelan J, Shay DK, Davis RL. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics 1999; 103:E3; PMID:9917483; http://dx.doi.org/10.1542/peds.103.1.e3
   PubMed Web of Science ®Google Scholar
• Ford-Jones EL, Wang E, Petric M, Corey P, Moineddin R, Fearon M. Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Archives of pediatrics & adolescent medicine 2000; 154:578-585; PMID:10850504; http://dx.doi.org/10.1001/archpedi.154.6.578
   PubMed Web of Science ®Google Scholar
• Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005; 54:1-40; PMID:16086456
   PubMedGoogle Scholar
• CA Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 2001; 20:63-75; PMID:11176570; http://dx.doi.org/10.1097/00006454-200101000-00013
   PubMed Web of Science ®Google Scholar
• Bernbaum JC, Daft A, Anolik R, Samuelson J, Barkin R, Douglas S, Polin R. Response of preterm infants to diphtheria-tetanus-pertussis immunizations. J Pediatr 1985; 107:184-8; PMID:3874942; http://dx.doi.org/10.1016/S0022-3476(85)80122-0
   PubMed Web of Science ®Google Scholar
• D'Angio CT, Maniscalco WM, Pichichero ME. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations. Pediatrics 1995; 96:18-22; PMID:7596716
   PubMed Web of Science ®Google Scholar
• Vazquez L, Garcia F, Ruttimann R, Coconier G, Jacquet JM, Schuerman L. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants. Acta Paediatr 2008; 97:1243-9; PMID:18489623; http://dx.doi.org/10.1111/j.1651-2227.2008.00884.x
   PubMed Web of Science ®Google Scholar
• Slack MH, Schapira D, Thwaites RJ, Schapira C, Bamber J, Burrage M, Southern J, Andrews N, Miller E. Acellular pertussis vaccine given by accelerated schedule: response of preterm infants. Arc Dis Child Fetal Neonatal Ed 2004; 89:57-60; PMID:14711858; http://dx.doi.org/10.1136/fn.89.1.F57
   PubMed Web of Science ®Google Scholar
• Slack MH, Cade S, Schapira D, Thwaites RJ, Crowley-Luke A, Southern J, Borrow R, Miller E. DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation. Arch Dis Child 2005; 90:338-4; PMID:15781918; http://dx.doi.org/10.1136/adc.2004.052720
   PubMed Web of Science ®Google Scholar
• Schloesser RL, Fischer D, Otto W, Rettwitz-Volk W, Herden P, Zielen S. Safety and immunogenicity of an acellular pertussis vaccine in premature infants. Pediatrics 1999; 103:e60; PMID:10224204; http://dx.doi.org/10.1542/peds.103.5.e60
   PubMedGoogle Scholar
• Faldella G, Alessandroni R, Magini GM, Perrone A, Sabatini MR, Vancini A, Salvioli GP. The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine. Vaccine 1998; 16:1646-9; PMID:9713941; http://dx.doi.org/10.1016/S0264-410X(98)00060-7
   PubMed Web of Science ®Google Scholar
• Esposito S, Faldella G, Giammanco A, Bosis S, Friscia O, Clerici M, Principi N. Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants. Vaccine 2002; 20:2928-32; PMID:12126904; http://dx.doi.org/10.1016/S0264-410X(02)00230-X
   PubMed Web of Science ®Google Scholar
• Omenaca F, Garcia-Sicilia J, Garcia-Corbeira P, Boceta R, Romero A, Lopez G, Dal-Ré R. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue. Pediatrics 2005; 116:1292-8; PMID:16322149; http://dx.doi.org/10.1542/peds.2004-2336
   PubMedGoogle Scholar
• Kirmani KI, Lofthus G, Pichichero ME, Voloshen T, D'Angio CT. Seven-year follow-up of vaccine response in extremely premature infants. Pediatrics 2002; 109:498-504; PMID:11875147; http://dx.doi.org/10.1542/peds.109.3.498
   PubMed Web of Science ®Google Scholar
• Robinson MJ, Campbell F, Powell P, Sims D, Thornton C. Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1999; 80:F69-71; PMID:10325817; http://dx.doi.org/10.1136/fn.80.1.F69
   PubMedGoogle Scholar
• Munoz A, Salvador A, Brodsky NL, Arbeter AM, Porat R. Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine. Pediatrics 1995; 96:216-9; PMID:7630672
   PubMed Web of Science ®Google Scholar
• Kristensen K, Gyhrs A, Lausen B, Barington T, Heilmann C. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatr Infect Dis J 1996; 15:525-9; PMID:8783350; http://dx.doi.org/10.1097/00006454-199606000-00010
   PubMed Web of Science ®Google Scholar
• Slack MH, Schapira D, Thwaites RJ, Burrage M, Southern J, Andrews N, Borrow R, Goldblatt D, Miller E. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines. J Infect Dis 2001; 184:1617-20; PMID:11740740; http://dx.doi.org/10.1086/324666
   PubMed Web of Science ®Google Scholar
• Baxter D, Ghebrehewet S, Welfare W, Ding DCD. Immunizing premature infants in a special care baby unit in the UK. Results of a prospective, non-inferiority based, pragmatic case series study. Hum Vacc 2010; 6:1-9; PMID:20421709; http://dx.doi.org/10.4161/hv.6.1.10702
   PubMed Web of Science ®Google Scholar
• Heath PT, Booy R, Griffiths H, Clutterbuck E, Azzopardi HJ, Slack MP, Fogarty J, Moloney AC, Moxon ER. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis 2000; 31:973-80; PMID:11049779; http://dx.doi.org/10.1086/318132
   PubMed Web of Science ®Google Scholar
• Lau YL, Tam AY, Ng KW, Tsoi NS, Lam B, Lam P, Yeung CY. Response of preterm infants to hepatitis B vaccine. J Pediatr 1992; 121:962-5; PMID:1447667; http://dx.doi.org/10.1016/S0022-3476(05)80352-X
   PubMed Web of Science ®Google Scholar
• Kim SC, Chung EK, Hodinka RL, DeMaio J, West DJ, Jawad AF, Watson B. Immunogenicity of hepatitis B vaccine in preterm infants. Pediatrics 1997; 99:534-6; PMID:9093293; http://dx.doi.org/10.1542/peds.99.4.534
   PubMed Web of Science ®Google Scholar
• Blondheim O, Bader D, Abend M, Peniakov M, Reich D, Potesman I, Handsher R, Gidoni I, Linder N. Immunogenicity of hepatitis B vaccine in preterm infants. Arch Dis Child Fetal Neonatal Ed 1998; 79:F206-8; PMID:10194993; http://dx.doi.org/10.1136/fn.79.3.F206
   PubMed Web of Science ®Google Scholar
• Losonsky GA, Wasserman SS, Stephens I, Mahoney F, Armstrong P, Gumpper K, Dulkerian S, West DJ, Gewolb IH. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization. Pediatrics 1999; 103:E14; PMID:9925860; http://dx.doi.org/10.1542/peds.103.2.e14
   PubMed Web of Science ®Google Scholar
• Belloni C, Chirico G, Pistorio A, Orsolini P, Tinelli C, Rondini G. Immunogenicity of hepatitis B vaccine in term and preterm infants. Acta Paediatr 1998; 87:336-8; PMID:9560044; http://dx.doi.org/10.1111/j.1651-2227.1998.tb01448.x
   PubMed Web of Science ®Google Scholar
• Esposito S, Pugni L, Bosis S, Proto A, Cesati L, Bianchi C, Cimino C, Mosca F, Principi N. Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants. Vaccine 2005; 23:1703-8; PMID:15705475; http://dx.doi.org/10.1016/j.vaccine.2004.09.029
   PubMed Web of Science ®Google Scholar
• Ruggeberg JU, Collins C, Clarke P, Johnson N, Sinha R, Everest N, Chang J, Stanford E, Balmer P, Borrow R, et al. Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants. Vaccine 2007; 25:264-71; PMID:17070968; http://dx.doi.org/10.1016/j.vaccine.2006.07.036
   PubMed Web of Science ®Google Scholar
• Omeñaca F, Merino JM, Tejedor JC, Constantopoulos A, Papaevangelou V, Kafetzis D, Tsirka A, Athanassiadou F, Anagnostakou M, François N, et al. Immunization of preterm infants with 10-valent pneumococcal conjugate vaccine. Pediatrics 2011; 128:e290-8; PMID:21727108; http://dx.doi.org/10.1542/peds.2010-1184
   PubMed Web of Science ®Google Scholar
• Martinón-Torres F, Czajka H, Center KJ, Wysocki J, Majda-Stanislawska E, Omeñaca F, Bernaola Iturbe E, Blazquez Gamero D, Concheiro-Guisán A, Gimenez-Sanchez F, et al. 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Preterm Versus Term Infants. Pediatrics 2015; 135:e876-86; PMID:25780077; http://dx.doi.org/10.1542/peds.2014-2941
   PubMed Web of Science ®Google Scholar
• CA Protocole d'immunisation du Québec. Section 10.3.3, p297-304. http://publications.msss.gouv.qc.ca/acrobat/f/documentation/piq/piq_complet.pdf
   Google Scholar
• Esposito S, Corbellini B, Bosis S, Pugni L, Tremolati E, Tagliabue C, Toneatto D, Mosca F, Principi N. Immunogenicity, safety and tolerability of meningococcal C CRM197 conjugate vaccine administered 3, 5 and 11 months post-natally to pre- and full-term infants. Vaccine 2007; 25:4889-94; PMID:17513025; http://dx.doi.org/10.1016/j.vaccine.2007.04.018
   PubMed Web of Science ®Google Scholar
• Collins CL, Ruggeberg JU, Balfour G, Tighe H, Archer M, Bowen-Morris J, Diggle L, Borrow R, Balmer P, Buttery JP, et al. Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants. Pediatr Infect Dis J 2005; 24:966-8; PMID:16282930; http://dx.doi.org/10.1097/01.inf.0000187027.45918.6a
   PubMed Web of Science ®Google Scholar
• Slack MH, Cade S, Schapira D, Thwaites RJ, Crowley-Luke A, Southern J, Borrow R, Miller E. DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation. Arch Dis Child 2005; 90:338-41; PMID:15781918; http://dx.doi.org/10.1136/adc.2004.052720
   PubMed Web of Science ®Google Scholar
• Omenaca F, Sarlangue J, Szenborn L, Nogueira M, Suryakiran PV, Smolenov IV, Han HH; ROTA-054 Study Group. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European infants: a randomized phase IIIb study. Pediatr Infect Dis J 2012; 31:487-93; PMID:22228231; http://dx.doi.org/10.1097/INF.0b013e3182490a2c
   PubMed Web of Science ®Google Scholar
• Roué JM, Nowak E, Le Gal G, Lemaitre T, Oger E, Poulhazan E, Giroux JD, Garenne A, Gagneur A. Impact of rotavirus vaccine on premature infants. Clin Vaccine Immunol 2014; 21:1404-9; PMID:25080553; http://dx.doi.org/10.1128/CVI.00265-14
   PubMed Web of Science ®Google Scholar
• Parashar UD, Alexander JP, Glass RI. Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006; 55(RR-12):1-13; PMID:16902398
   PubMedGoogle Scholar
• CA American Academy of Pediatrics Committee on Infectious Diseases. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics 2007; 119:171-181; PMID:17200286; http://dx.doi.org/10.1542/peds.2006-3134
   PubMed Web of Science ®Google Scholar
• Pinquier D, Gagneur A, Aubert M, Brissaud O, Le Guen CG, Hau-Rainsard Picherot G, De Pontual L, Stephan JL, Reinert P. Distribution of serum measles-neutralizing antibodies according to age in women of childbearing age in France in 2005-2006: impact of routine immunization. Pediatr Infect Dis J 2007; 26:749-50; PMID:17848891; http://dx.doi.org/10.1097/INF.0b013e31806211aa
   PubMed Web of Science ®Google Scholar
• Gagneur A, Pinquier D, Aubert M, Soubeyrand B, Balu L, Brissaud O, De Pontual L, Gras Le Guen C, Hau-Rainsard I, Mory O, et al. Kinetics of decline of maternal measles virus neutralizing antibodies in sera of infants in France in 2006. Clin Vaccine Immunol 2008; 15:1845-50; PMID:18815232; http://dx.doi.org/10.1128/CVI.00229-08
   PubMed Web of Science ®Google Scholar
• Linder N, Tallen-Gozani E, German B, Duvdevani P, Ferber A, Sirota L. Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status. Vaccine 2004; 22:1509-14; PMID:15063576; http://dx.doi.org/10.1016/j.vaccine.2003.10.009
   PubMed Web of Science ®Google Scholar
• Leineweber B, Grote V, Schaad UB, Heininger U. Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicellazoster virus in preterm and full term newborns. Pediatr Infect Dis J 2004; 23:361-3; PMID:15071296; http://dx.doi.org/10.1097/00006454-200404000-00019
   PubMed Web of Science ®Google Scholar
• Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P. Early waning of maternal measles antibodies in era of measles elimination: longitudinal study. BMJ 2010; 340:c1626; PMID:20483946; http://dx.doi.org/10.1136/bmj.c1626
   PubMed Web of Science ®Google Scholar
• Gagneur A, Pinquier D. Spotlight on measles 2010: timely administration of the first dose of measles vaccine in the context of an ongoing measles outbreak in France Euro Surveill 2010; 15:19689; PMID:20961512
   PubMed Web of Science ®Google Scholar
• Gagneur A, Pinquier D. Early waning of maternal measles antibodies: why immunization programs should be adapted over time. Expert Rev Anti Infect Ther 2010; 8:1339-43; PMID:21133659; http://dx.doi.org/10.1586/eri.10.126
   PubMed Web of Science ®Google Scholar
• Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J Audet S, Maldonado Y, Arvin AM. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. J Infect Dis 2004; 190:83-90; PMID:15195246; http://dx.doi.org/10.1086/421032
   PubMed Web of Science ®Google Scholar
• Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 1998; 28:527-32; PMID:9707142; http://dx.doi.org/10.1001/jama.280.6.527
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Tsuji A, Fujino M, Kusano R, Sugiyama R, Oomori S, Mori K, Maeyama K, Nakayama T. Effect of early measles vaccination (AIK-C strain) for preterm infants. Pediatr Int 2013; 55:163-8; PMID:23379893; http://dx.doi.org/10.1111/ped.12064
   PubMed Web of Science ®Google Scholar
• Groothuis JR, Levin MJ, Lehr MV, Weston JA, Hayward AR. Immune response to split-product influenza vaccine in preterm and full-term young children. Vaccine 1992; 10:221-5; PMID:1561829; http://dx.doi.org/10.1016/0264-410X(92)90156-E
   PubMed Web of Science ®Google Scholar
• D'Angio CT, Heyne RJ, Duara S, Holmes LC, O'Shea TM, Wang H, Wang D, Sánchez PJ, Welliver RC, Ryan RM, et al. Immunogenicity of trivalent influenza vaccine in extremely low-birth-weight, premature versus term infants. Pediatr Infect Dis J 2011; 30:570-4; PMID:21273938; http://dx.doi.org/10.1097/INF.0b013e31820c1fdf
   PubMed Web of Science ®Google Scholar
• CA Pinquier D, Gagneur A, Gras-Le Guen C, Blandin S, Stephan J-L, Régnier F, Picherot G, Brissaud O, Marpeau L, Marret S, et al. Vaccine prevention in perinatal health care: parents children and professionals. Gynecol Obstet Fertil 2008; 36:461-8; PMID:18417409; http://dx.doi.org/10.1016/j.gyobfe.2008.02.015
   PubMed Web of Science ®Google Scholar
• Pinquier D, Gagneur A, Gaudelus J, Marret S. Preventive vaccination strategy around the birth. Rev Prat 2010; 30:1363-7
   Google Scholar
• CA Carbone T, McEntire B, Kissin D, Kelly D, Steinschneider A, Violaris K, Karamchandani N. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infant: a randomized multi center study. Pediatrics 2008; 121:e1085-90; PMID:18450851; http://dx.doi.org/10.1542/peds.2007-2059
   PubMedGoogle Scholar
• Pinquier D, Adde-Michel C, Ploin D, Leveque C, Marret S. Vaccination rate of preterm infants at 6 and 24 months of age: a pilot study. Arch Pediatr 2009; 16:1533-9; PMID:19854629; http://dx.doi.org/10.1016/j.arcped.2009.09.009
   PubMed Web of Science ®Google Scholar
• Magoon MW, Belardo IJ, Caldito G. Delays in immunizations of high-risk infants during the first two years of life: special care for the high risk infant should not mean special immunization schedules. J Perinatol 1995; 15:222-8; PMID:7666272
   PubMedGoogle Scholar
• Langkamp DL, Hoshaw-Woodard S, Boye ME, Lemeshow S. Delays in receipt of immunization in low-birth weight children. Arch Pediatr Adolesc Med 2001; 155:167-72; PMID:11177092; http://dx.doi.org/10.1001/archpedi.155.2.167
   PubMed Web of Science ®Google Scholar
• Quinn HE, Snelling TL, Habig A, Chiu C, Spokes PJ, McIntyre PB. Parental Tdap boosters and infant pertussis: a case-control study. Pediatrics. 2014; 134:713-20; PMID:25225136; http://dx.doi.org/10.1542/peds.2014-1105
   PubMed Web of Science ®Google Scholar
• Rosenblum E, McBane S, Wang W, Sawyer M. Protecting newborns by immunizing family members in a hospital-based vaccine clinic: a successful Tdap cocooning program during the 2010 California pertussis epidemic. Public Health Rep 2014; 129:245-51; PMID:24791022
   PubMed Web of Science ®Google Scholar